Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) in a report issued on Thursday. The brokerage set a “buy” rating on the stock.

Other equities analysts have also issued research reports about the stock. Jefferies Financial Group lowered shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to an “underperform” rating and cut their price target for the stock from $14.00 to $11.70 in a report on Monday, January 2nd. Sanford C. Bernstein began coverage on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, March 7th. They set a “market perform” rating on the stock. Truist Financial lifted their price target on shares of Fresenius Medical Care AG & Co. KGaA from $17.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, February 23rd. Finally, HSBC lowered shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “reduce” rating in a report on Tuesday, March 7th. Four analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $28.20.

Fresenius Medical Care AG & Co. KGaA Stock Performance

NYSE FMS opened at $19.58 on Thursday. The firm’s fifty day moving average price is $18.98 and its two-hundred day moving average price is $16.54. The stock has a market cap of $11.49 billion, a PE ratio of 16.32 and a beta of 1.00. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of $12.78 and a fifty-two week high of $34.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.91 and a current ratio of 1.27.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

Hedge funds and other institutional investors have recently bought and sold shares of the stock. CWM LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 82.0% in the third quarter. CWM LLC now owns 1,753 shares of the company’s stock valued at $25,000 after purchasing an additional 790 shares in the last quarter. Wipfli Financial Advisors LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA in the third quarter valued at $25,000. Sandy Spring Bank bought a new stake in Fresenius Medical Care AG & Co. KGaA in the fourth quarter valued at $27,000. Clear Street Markets LLC bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the fourth quarter worth about $28,000. Finally, Ronald Blue Trust Inc. increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 1,156.0% during the fourth quarter. Ronald Blue Trust Inc. now owns 3,366 shares of the company’s stock worth $48,000 after acquiring an additional 3,098 shares in the last quarter. 5.56% of the stock is owned by institutional investors.

About Fresenius Medical Care AG & Co. KGaA

(Get Rating)

Fresenius Medical Care AG & Co KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America, EMEA, Asia-Pacific, and Latin America.